Deficiency of the type I interferon receptor protects mice from experimental lupus.
about
Role of type I interferons in the activation of autoreactive B cellsA BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responsesConstitutive type I interferon modulates homeostatic balance through tonic signalingGenetic complementation results in augmented autoantibody responses to lupus-associated antigens.High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus.IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosusRecent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.Dendritic cells in systemic lupus erythematosusInterferons and their stimulated genes in the tumor microenvironmentSerum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalinMurine B cell response to TLR7 ligands depends on an IFN-beta feedback loopGender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunityEarly, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells.Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damageMurine models of systemic lupus erythematosusRequirements for innate immune pathways in environmentally induced autoimmunity.The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.Toxicology of autoimmune diseases.Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity.Animal Models of Interferon Signature Positive Lupus.Toll-like receptors: potential targets for lupus treatmentType I interferon-dependent CD86(high) marginal zone precursor B cells are potent T cell costimulators in micemiR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cellsMyeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onsetJanus-like effects of type I interferon in autoimmune diseases.B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus.Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosisInnate pathways to B-cell activation and tolerance.IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells.Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed miceIRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice.A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients.Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupusEstrogen Receptor α Deficiency Modulates TLR Ligand-Mediated PDC-TREM Expression in Plasmacytoid Dendritic Cells in Lupus-Prone Mice.Taming lupus-a new understanding of pathogenesis is leading to clinical advances.
P2860
Q26858821-4D09DF62-DC7A-4707-AD1A-1B437BCE0DBFQ28118033-B388E91D-DAF6-466C-9728-AA754AF07539Q28260631-EFD2DFBD-2F76-4AB8-8646-2E105DEDD401Q30434941-23CD795F-240A-43D6-BB12-4F4F915CB1FFQ33523155-4494760A-978E-4B42-9576-089F2529F2D1Q33804141-CDA63EF4-D5B5-4B2C-82AC-B46316F8D1AFQ33806541-97A44A38-D524-46DB-90A7-367DD2480EE8Q33941433-7E68662D-4C10-48C6-BD53-18F80F083F64Q33988567-B1B4CFD1-CE2F-4F64-B9AB-24F22F00DCAFQ33992328-E40AA9CB-696E-49EA-B31E-24451D41CA10Q34090517-677553FD-C122-493B-BC9B-9EB615691DA7Q34187236-F37F7BF2-85EE-4DB6-B99B-18A929828F3BQ34230589-3863BECE-4AED-4CC7-8E7E-2F9439044968Q34240254-652CE97F-1850-4EC7-B301-286F9794DBA9Q34420821-C7127EA2-CEF4-4FB8-867C-95DA0474EB52Q34443260-EB1F93B3-E9AB-4267-A561-44E29D536224Q34591019-57407F40-8456-436E-BCD2-84ADD0EA99DAQ34655526-A5DA6CAD-4EF6-4CC4-9B10-B7B92452CCFBQ34779998-9246EB40-261E-40CE-95CF-36BAF5DF5629Q34781487-D603A2D6-C0EA-458C-978A-D16E3641F1D2Q34788943-94B846DB-85AC-4581-AE3D-EE48FC2239F4Q34790990-DA24A59C-CBC0-4A90-ABD1-36E385470639Q35152132-0B86874D-71F6-4D0F-8DFC-128234CC2A44Q35685720-B117CBAF-2017-48CB-9C6E-010EFF7C4863Q35686914-8A9DBE3F-C4AA-40A5-B3A2-49256D447A55Q35848152-94E417C7-4190-4BE1-81B4-B74987A377CDQ35848476-0A42F7C2-2CD7-4407-8ADE-79BD911FE071Q35936143-B41DF253-E514-40D0-AC71-CF5C074761C9Q36054583-F5521B7C-4BBD-4B54-9990-9FA9BCE1EAE0Q36059960-FAB6006F-B022-4555-A71E-467EA90D6C6BQ36091161-B2E4DC4D-3099-4577-A62D-A238E46783A0Q36139902-412F2131-DCED-43F9-91C0-392DD6A644C0Q36172913-3AF1F0AF-4DC3-416D-9496-DF647D9F75B9Q36232213-0A2767C7-1F7B-4F55-9B5A-0EF26DAB138BQ36490737-C1144592-7BA4-4FD7-B9A8-8D63205DC2FDQ36494607-E3723B04-CEDF-4198-875F-11855AA7FC7FQ36549197-1D3CD948-77D3-400A-8C4B-59DCDB2E66ECQ36632390-B14852D6-5358-4DBA-8913-26739062751AQ36682785-55755874-FAA0-4B31-95F7-86393472D933Q36712941-46E5EDB8-F8F2-4EB5-AD95-BA8D665A7FF0
P2860
Deficiency of the type I interferon receptor protects mice from experimental lupus.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@ast
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@en
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@nl
type
label
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@ast
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@en
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@nl
prefLabel
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@ast
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@en
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@nl
P2093
P2860
P356
P1476
Deficiency of the type I interferon receptor protects mice from experimental lupus.
@en
P2093
Dina C Nacionales
Eric Sobel
Jason S Weinstein
Kindra M Kelly-Scumpia
Minoru Satoh
Robert Lyons
Westley H Reeves
P2860
P304
P356
10.1002/ART.23023
P577
2007-11-01T00:00:00Z